PCOS renamed to PMOS: New name reflects metabolic focus

PCOS gets a new name

Polycystic ovarian syndrome (PCOS) has been officially renamed. The condition will now be known as Polycystic Metabolic Syndrome (PMOS). Experts say the change is long overdue.

For decades, the name focused on the ovaries. But doctors now agree the core problem is metabolic dysfunction, not just cysts. The new name aims to reduce confusion and stigma.

Lancet study links PMOS to heart disease

The renaming coincides with a major study published in The Lancet. Researchers found that women with PMOS have a four times higher risk of heart disease compared to those without the condition.

The study warns of increased risks of heart attacks and strokes, especially in younger women. This is the first time such a strong link has been quantified in a large-scale analysis.

Dr. Meera Sharma, an endocrinologist not involved in the study, said the findings are a wake-up call. “We have long known PCOS is not just about reproduction. This data confirms it is a systemic metabolic disorder,” she said.

What the new name means for patients

Doctors expect the rename to change how the condition is diagnosed and treated. Instead of focusing only on ovarian cysts, screening will now include metabolic markers like insulin resistance and cholesterol levels.

Patients have reported years of delayed diagnosis. One woman told reporters it took five years to be diagnosed with the painful condition. The new name may help speed up recognition in primary care.

Health activists argue the change will also reduce the misconception that the condition is solely about fertility. Many women with PMOS struggle with weight, fatigue, and heart risks.

Global reaction to the rename

Medical bodies in India, the UK, and the US have endorsed the change. The Indian Council of Medical Research has already updated its guidelines to use the term PMOS.

Some patient groups have welcomed the move but caution that awareness campaigns are needed. Simply changing a name without educating doctors and the public may not help.

The Lancet study authors recommend that all women diagnosed with PMOS should receive annual cardiovascular risk assessments. This includes blood pressure checks, lipid profiles, and glucose tolerance tests.

What happens next

Medical journals and textbooks will gradually adopt the new terminology over the next year. The World Health Organization is expected to update its classification codes shortly.

For now, women who were previously diagnosed with PCOS will not need to be re-diagnosed. But their doctors should update their records and begin metabolic screening as per the new guidelines.